Contract Services Contract Manufacturing
BD launches its second center of excellence in flow cytometry for clinical research at CMC In India
The CoE at CMC Vellorewill help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis with highe...
October 25, 2021 | News
Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...
October 25, 2021 | News
Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy
Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...
October 13, 2021 | News
Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan
The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and pharmaceutical companies. The facili...
October 10, 2021 | News
Vetter/Syntegon partnership scores PDA Drug Delivery Innovation Award
With demand for niche and orphan drugs continuing to surge, Vetter and Syntegon recently synced their expertise to advance the industry’s approach to...
October 07, 2021 | News
CPhI Report predicts record EBITDAs for CDMOs in 2022
Part one of the 2021 CPhI Annual Report predicts an increasingly bullish outlook for CDMOs in the next 2-3 years, with macro factors significantl...
September 28, 2021 | News
Samsung Biologics introduced its CDO process platform, S-Cellerate(TM), at BPI 2021
Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at t...
September 23, 2021 | News
WuXi Biologics Completes SARS-CoV-2 Protein Synthesis for BVX-0320 and CoviDTH
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys"), announced that CDMO's global partner WuXi Biologics has completed the syn...
September 15, 2021 | News
GenScript ProBio to Manufacture Innovative Antibody Drug
FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...
September 06, 2021 | News
WuXi Biologics Received First Manufacturing License from Japan
WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...
September 02, 2021 | News
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate
This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...
August 03, 2021 | News
CliniRx to offer full suite of Rave EDC and CDM services to sponsors
CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...
July 30, 2021 | News
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility
Marker Therapeutics, Inc. a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapi...
July 30, 2021 | News
WuXi Biologics Received First GMP manufacturing authorization outside of China
First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...
July 26, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
